A third-party headline asked whether United Therapeutics could join the S&P 500. The supplied facts don’t confirm an index addition or explain the company’s eligibility.
Published on October 20, the headline asked whether United Therapeutics could “finally crack the S&P 500.” But the supplied facts include no index decision, company announcement, or analysis of the selection criteria. They show recent stock performance and trading volume, not that an index change is underway.
Investor takeaway: The headline raises a question; it doesn’t report an index decision. The supplied facts show no change to United Therapeutics’ index status.
Advertisement
United Therapeutics Corporation
UTHR.US
UTHR.US
United Therapeutics Corporation
WealthAwesomeMarket cap
$24.17B
P/E
20.2x
52W high
$609.35
52W low
$409.07
1W change
+4.34%
Beta
0.49
Analyst Price Targets
Based on 15 analysts covering UTHR · as of Oct 22, 2026
Wall Street analysts forecast UTHR stock price to rise 17.5% over the next 12 months.
Consensus
Buy4.13 / 5.00
Avg. Target
C$662.07
+17.5% Upside
Previously C$659.79 on Oct 21, 2026
Current Price
C$563.49
Last close
Analyst Breakdown (15 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on UTHR's historical volatility
30-Day Vol
46.6%
Annualized
90-Day Vol
33.0%
Annualized
Trend (90d)
+30.8%
Annualized drift
90d Mean
C$629.04
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$584.54 | C$497.71 – C$686.53 |
| 60 trading days | C$606.38 | C$483.03 – C$761.24 |
| 90 trading days | C$629.04 | C$476.11 – C$831.10 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
US$584.78 last close; 110,753 shares traded
United Therapeutics closed at US$584.78. The latest volume was 110,753 shares, or 0.49 times the 20-day average of 896,179 shares. The supplied facts don’t link that trading session to the S&P 500 headline.
Bull case
The supplied figures show a 41.6% profit margin and a market capitalization of about US$24.2 billion. The stock also posted gains over the listed periods.
Bear case
The headline doesn’t confirm S&P 500 inclusion. Latest reported volume was also below the 20-day average.
The headline posed a question, not an index announcement
The October 20 EOD headline, “United Therapeutics (UTHR): Can the Profit-Machine Biotech Finally Crack the S&P 500?”, is a third-party recap framed as a question. The supplied facts don’t say United Therapeutics has joined the S&P 500, that an addition has been announced, or that a decision is pending. They also include no eligibility analysis or index-selection details. So the headline shouldn’t be read as confirmation of a change in the company’s index status. Investors can find listing information on the United Therapeutics stock page.
Advertisement
The supplied figures show gains and below-average volume
United Therapeutics’ last close was US$584.78. The supplied performance figures were +1.74% for one day, +4.34% for one week, +14.27% for one month, and +13.44% year to date. Latest volume was 110,753 shares, or 0.49 times the 20-day average of 896,179 shares. That comparison doesn’t show a reaction to the S&P 500 headline.
The reported 52-week range was US$409.07 to US$609.35, with the last close at 88% of the range. Other supplied figures include a 41.6% profit margin and a market capitalization of US$24,168,474,624. These numbers provide context but don’t establish index eligibility.
What to watch: an actual index update
The supplied facts include no formal S&P 500 decision or company-specific update. United Therapeutics is scheduled to report third-quarter 2026 results before the market opens on November 4, according to the company-news listing. That’s a separate upcoming event and doesn’t confirm an index change. Investors following the headline can look for a formal index announcement and check company updates on the UTHR stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
